Award
National Cancer Institute 5R01CA292377-02
Targeted degradation of CDK4 and 6 to overcome treatment resistance in breast cancer
Recipient
UT SOUTHWESTERN MEDICAL CENTER
Awarded
June 12, 2026
Identifier
5R01CA292377-02
NIH grant awarded for research on targeted degradation of CDK4/6 to overcome treatment resistance in breast cancer using genomic and machine learning methods.
Description
This is a NIH grant project focused on developing therapeutic strategies targeting CDK4/6 in breast cancer. The project involves advanced genomic and machine learning approaches, and aims to evaluate the efficacy of a CDK4/6 degrader in resistant breast cancer models.